UK markets close in 2 hours 37 minutes

ABIVAX Société Anonyme (AAVXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
15.150.00 (0.00%)
At close: 11:40AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,621
4,621
4,583
11,962
0
Cost of revenue
-
-
50,764
45,517
33,783
Gross profit
-
-
-50,764
-45,517
-33,783
Operating expenses
Research development
103,176
103,176
48,295
47,781
-
Selling general and administrative
14,007
14,007
6,090
3,259
33,278
Total operating expenses
131,997
131,997
55,788
53,360
4,226
Operating income or loss
-127,376
-127,376
-51,205
-41,398
-38,009
Interest expense
13,826
13,826
6,940
3,558
2,062
Income before tax
-147,740
-147,740
-60,740
-42,452
-40,127
Income tax expense
0
0
0
0
-2,575
Income from continuing operations
-147,740
-147,740
-60,740
-42,452
-37,552
Net income
-147,740
-147,740
-60,740
-42,452
-37,551
Net income available to common shareholders
-147,740
-147,740
-60,740
-42,452
-37,551
Basic EPS
-2.43
-
-3.18
-2.75
-2.62
Diluted EPS
-2.43
-
-3.18
-2.75
-2.62
Basic average shares
17,086
-
19,092
15,456
14,332
Diluted average shares
42,536
-
19,092
15,456
14,332